User profiles for Etienne Simon-Lorière
 | Etienne Simon-LoriereInstitut Pasteur, Virology department Verified email at pasteur.fr Cited by 10866 |
[HTML][HTML] Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
…, T Prazuck, H Mouquet, T Bruel, E Simon-Lorière… - Nature, 2021 - nature.com
The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India 1 , 2 , 3 , 4 – 5 .
Since then, it has become dominant in some regions of India and in the UK, and has spread to …
Since then, it has become dominant in some regions of India and in the UK, and has spread to …
[HTML][HTML] Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies
…, H Péré, D Veyer, A Sève, E Simon-Lorière… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 and B.1.351 variants
were first identified in the United Kingdom and South Africa, respectively, and have since …
were first identified in the United Kingdom and South Africa, respectively, and have since …
Structural basis of potent Zika–dengue virus antibody cross-neutralization
…, MC Vaney, I Medits, A Sharma, E Simon-Lorière… - Nature, 2016 - nature.com
Zika virus is a member of the Flavivirus genus that had not been associated with severe disease
in humans until the recent outbreaks, when it was linked to microcephaly in newborns in …
in humans until the recent outbreaks, when it was linked to microcephaly in newborns in …
[HTML][HTML] A novel SARS-CoV-2 related coronavirus in bats from Cambodia
…, P Dussart, T Goldstein, E Simon-Lorière… - Nature …, 2021 - nature.com
Abstract Knowledge of the origin and reservoir of the coronavirus responsible for the
ongoing COVID-19 pandemic is still fragmentary. To date, the closest relatives to SARS-CoV-2 …
ongoing COVID-19 pandemic is still fragmentary. To date, the closest relatives to SARS-CoV-2 …
[HTML][HTML] Humoral immune escape by current SARS-CoV-2 variants BA. 2.86 and JN. 1, December 2023
…, J Jansen, A Krumbholz, E Simon-Lorière… - …, 2024 - eurosurveillance.org
Variant BA.2.86 and its descendant, JN.1, of SARS-CoV-2 are rising in incidence across
Europe and globally. We isolated recent JN.1, BA.2.86, EG.5, XBB.1.5 and earlier variants. We …
Europe and globally. We isolated recent JN.1, BA.2.86, EG.5, XBB.1.5 and earlier variants. We …
[PDF][PDF] Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA. 2, BA. 4, and BA. 5 in patients receiving monoclonal antibodies
…, L Handala, C Planchais, M Prot, E Simon-Lorière… - Cell Reports …, 2022 - cell.com
The emergence of Omicron sublineages impacts the therapeutic efficacy of anti-severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies (mAbs). Here, …
respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies (mAbs). Here, …
Reduced sensitivity of infectious SARS-CoV-2 variant B. 1.617. 2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
…, T Prazuck, H Mouquet, T Bruel, E Simon-Lorière… - Biorxiv, 2021 - biorxiv.org
The SARS-CoV-2 B.1.617 lineage emerged in October 2020 in India 1 – 6 . It has since then
become dominant in some indian regions and further spread to many countries. The …
become dominant in some indian regions and further spread to many countries. The …
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant
…, J Megret, JM Pawlotsky, S Fillatreau, E Simon-Lorière… - Immunity, 2022 - cell.com
The SARS-CoV-2 Omicron variant can escape neutralization by vaccine-elicited and
convalescent antibodies. Memory B cells (MBCs) represent another layer of protection against …
convalescent antibodies. Memory B cells (MBCs) represent another layer of protection against …
[HTML][HTML] Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA. 1 and BA. 2
…, F Agou, JD Dimitrov, E Simon-Lorière… - Journal of Experimental …, 2022 - rupress.org
Disclosures: C. Planchais reported a patent to PCT/EP2022/058777 licensed (SpikImm). I.
Fernández reported a patent to PCT/EP2022/058777 licensed (SpikImm). T. Bruel reported a …
Fernández reported a patent to PCT/EP2022/058777 licensed (SpikImm). T. Bruel reported a …
Zika virus induces massive cytoplasmic vacuolization and paraptosis‐like death in infected cells
The cytopathic effects of Zika virus ( ZIKV ) are poorly characterized. Innate immunity controls
ZIKV infection and disease in most infected patients through mechanisms that remain to be …
ZIKV infection and disease in most infected patients through mechanisms that remain to be …